A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

Researchers are looking for new ways to treat diabetic macular edema (DME). In this trial, researchers want to learn if a trial medicine called MK-8748 can treat DME. An available standard (usual) treatment for DME is aflibercept. However, standard treatments such as aflibercept may not work for every person. The main goal of this trial is to learn if MK-8748 works as well as aflibercept to treat DME.

NCT Number	NCT07705607
Lead Sponsor	Merck Sharp & Dohme LLC
Conditions	Diabetic Retinopathy, Macular Edema
Enrollment	1,104 participants
Start Date	2026-09-30
Primary Completion	2028-11-30 (estimated)
Study Completion	2029-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-15